Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: An analysis of safety and efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiofrequency ablation for hepatic oligometastatic pancreatic cancer: An analysis of safety and efficacy

Published:2017-11 Issue:6 Volume:17 Page:967-973
ISSN:1424-3903
Container-title:Pancreatology
language:en
Short-container-title:Pancreatology

Author:

Hua Yong-Qiang,Wang Peng,Zhu Xiao-Yan,Shen Ye-Hua,Wang Kun,Shi Wei-Dong,Lin Jun-Hua,Meng Zhi-Qiang,Chen Zhen,Chen Hao^ORCID

Funder

National Nature Science Foundation of China

Innovation and Connotation Construction Foundation of T.C.M of Shanghai Municipal Commission Of Health and Family Planning

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Endocrinology, Diabetes and Metabolism

Reference40 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

3. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer;Cunningham;J Clin Oncol,2009

4. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial;Louvet;J Clin Oncol,2005

5. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer;Conroy;N Engl J Med,2011

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver Oligometastasis in Biliary Tract Cancer and Impact on Survival Outcomes;Journal of Gastrointestinal Cancer;2024-08-15

2. Surgery for Oligometastatic Pancreatic Cancer: Defining Biologic Resectability;Annals of Surgical Oncology;2024-03-19

3. Radical resection benefits patients suffering pancreatic ductal adenocarcinoma with liver oligometastases;Annals of Surgical Treatment and Research;2024

4. Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus;ESMO Open;2023-12

5. Oligo‐like liver metastasis: A novel prognostic indicator to improve survival in pancreatic cancer;Annals of Gastroenterological Surgery;2023-11-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3